Simulations Plus, Inc. Q4 2025 Earnings Recap

Simulations Plus delivered strong fiscal 2025 results with a 13% increase in total revenue, while navigating a challenging market landscape. A strategic transition to a unified operating model is set to enhance operational capacity and responsiveness.

Key Takeaways

• Revenue for the fourth quarter decreased 6% to $17.5 million, attributed to external market pressures.
• Full-year adjusted EBITDA and EPS both increased by 8%, reflecting operational resilience despite significant industry headwinds.
• The successful transition to a unified operating model positions the company for accelerated growth, capitalizing on the increasing adoption of biosimulation tools in R&D environments.
• Customer engagement is improving, as evidenced by increased proposal activity and a strong 88% renewal rate for the fiscal year.
• Continued investment in AI-driven solutions and cloud capabilities to enhance product offerings and support long-term demand in the biopharma sector.